Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Journal of Inflammatory Bowel Diseases & Disorders
|
October 18, 2021
Telomere Dysfunction as an Initiator of Inflammation: Clues to an Age-Old Mystery
Deepavali Chakravarti, Ronald A DePinho
Nature Reviews. Cancer
|
January 25, 2013
p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis
Xiaohua Su, Deepavali Chakravarti, Elsa R Flores
Cell
|
January 15, 2021
Telomeres: history, health, and hallmarks of aging
Deepavali Chakravarti, Kyle A LaBella, Ronald A DePinho
Trends in Pharmacological Sciences
|
March 12, 2022
Selective tyrosine kinase 2 inhibitors in inflammatory bowel disease
Ole Haagen Nielsen, Theresa Louise Boye, Deepavali Chakravarti, et al.
Genes & Development
|
June 2, 2021
Genetic and biological hallmarks of colorectal cancer
Jiexi Li, Xingdi Ma, Deepavali Chakravarti, et al.
Iscience
|
July 1, 2024
Organoids as regenerative medicine for inflammatory bowel disease
Alexander Hammerhøj, Deepavali Chakravarti, Toshiro Sato, et al.
Pharmacology & Therapeutics
|
April 2, 2023
Selective JAK1 inhibitors for the treatment of inflammatory bowel disease
Ole Haagen Nielsen, Theresa Louise Boye, John Gubatan, et al.
Cancer Research Communications
|
January 2, 2024
Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses
Marco Napoli, Avani A Deshpande, Deepavali Chakravarti, et al.
Cell Metabolism
|
October 9, 2012
TAp63 is a master transcriptional regulator of lipid and glucose metabolism
Xiaohua Su, Young Jin Gi, Deepavali Chakravarti, et al.
Genes & Development
|
September 29, 2023
Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer
Jincheng Han, Jiaqian Xu, Yonghong Liu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Journal of Inflammatory Bowel Diseases & Disorders
|
October 18, 2021
Telomere Dysfunction as an Initiator of Inflammation: Clues to an Age-Old Mystery
Deepavali Chakravarti, Ronald A DePinho
Nature Reviews. Cancer
|
January 25, 2013
p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis
Xiaohua Su, Deepavali Chakravarti, Elsa R Flores
Cell
|
January 15, 2021
Telomeres: history, health, and hallmarks of aging
Deepavali Chakravarti, Kyle A LaBella, Ronald A DePinho
Trends in Pharmacological Sciences
|
March 12, 2022
Selective tyrosine kinase 2 inhibitors in inflammatory bowel disease
Ole Haagen Nielsen, Theresa Louise Boye, Deepavali Chakravarti, et al.
Genes & Development
|
June 2, 2021
Genetic and biological hallmarks of colorectal cancer
Jiexi Li, Xingdi Ma, Deepavali Chakravarti, et al.
Iscience
|
July 1, 2024
Organoids as regenerative medicine for inflammatory bowel disease
Alexander Hammerhøj, Deepavali Chakravarti, Toshiro Sato, et al.
Pharmacology & Therapeutics
|
April 2, 2023
Selective JAK1 inhibitors for the treatment of inflammatory bowel disease
Ole Haagen Nielsen, Theresa Louise Boye, John Gubatan, et al.
Cancer Research Communications
|
January 2, 2024
Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses
Marco Napoli, Avani A Deshpande, Deepavali Chakravarti, et al.
Cell Metabolism
|
October 9, 2012
TAp63 is a master transcriptional regulator of lipid and glucose metabolism
Xiaohua Su, Young Jin Gi, Deepavali Chakravarti, et al.
Genes & Development
|
September 29, 2023
Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer
Jincheng Han, Jiaqian Xu, Yonghong Liu, et al.
Page
of 3